During this developing COVID-19 outbreak, Livengrin is committed to protecting our patients, families and staff from the spread of this virus (Coronavirus). As an essential provider of healthcare services, Livengrin plans to remain open and fully operational throughout this emergency. We are taking extraordinary infection-control precautions at all our facilities to maintain a healthy and safe environment. Please contact us with any questions or concerns regarding this situation at info@livengrin.org
In response to the COVID-19 crisis, safety and prevention of virus transmission are Livengrin’s top priorities. Therefore, we are announcing the following: All of our outpatient programs (including DUI classes) will be provided via Telehealth. All visitation has been canceled until further notice. Video conferencing or alternative measures for family contact can be fulfilled upon request. Additionally, the Friends and Fundraising Breakfast has been postponed until Fall 2020 - official date to follow. Please check back here for developing announcements.
Executive Team2020-01-27T13:47:08-05:00

The Livengrin Executive Team

A dedicated group of thought leaders committed to treatment advancement and support of long̴‑term recovery.

Executive Team

David Blenk

President & CEO

Dr. James W. Cornish, M.D.

Medical Director

Holly Livingston, M.S.W.

Vice President | Business Development

Hai H. Nguyen, C.P.A.

Vice President | Finance 

Michael Astringer

Interim Vice President | Talent 

Board of Directors

Bruce R. Murray

Allen W. Toadvine, Esq.

Pamela S. Janvey

Joseph P. McNally

Jay Weintraub

Joseph Guglielmi

Walt Higgins

Michael Astringer
*Temporary Leave

Melissa Santarelli, MBA

Anne F. Berlin

Eileen M. Bonner, M.D.

Ronald W. Davis

Edward J. Haaz

John Kane

Joseph R. Jingoli

Steven Leckerman

Rob Leipziger